[Pre-effective amendment No. 1 to FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Biostar Pharmaceuticals, Inc. Maryland (State or other jurisdiction of incorporation or organization) 2834 (Primary Standard Industrial Code Number) 20-8747899 (I.R.S. Employer Identification Number) No]
[SCHEDULE 13D (Rule 13d-101) (Amendment No. 3) RULE 13d-2(a) JPMorgan China Region Fund, Inc. (Name of Issuer) Common Stock, par value $.01 per share (Title of Class of Securities) 48126T104 (CUSIP Number) Barry M. Olliff c/o City of London Investment Management Company Limited 77 Gracechurch Street,]
[SCHEDULE 13D (Rule 13d-101) (Amendment No. 3) RULE 13d-2(a) JPMorgan China Region Fund, Inc. (Name of Issuer) Common Stock, par value $.01 per share (Title of Class of Securities) 48126T104 (CUSIP Number) Barry M. Olliff c/o City of London Investment Management Company Limited 77 Gracechurch Street,]
[FORM 10-K (Mark One) September 30, 2016 For the fiscal year ended: For the transition period from _____________ to _____________ 001-32898 Commission File No. CHINA BAK BATTERY, INC. Nevada 88-0442833 (State or Other Jurisdiction of Incorporation or (I.R.S. Employer Identification No.) Organization)]
